Simmi Wiggins

Company: Sanofi

Job title: Global Lead - Immunology and Medical

Seminars:

Unravelling New Mechanisms in Itch From Targeting Type 2 Inflammation 9:00 am

Understanding shared and unique characteristics of AD, PN and CSU How type 2 inflammation contributes to neuroimmune dysregulation  Potential for IL-4Ra antagonism to reduce itch in chronic inflammatory skin diseases.Read more

day: Day One